BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 3683637)

  • 1. [Results of a multicenter study of the efficacy of recombinant alpha-2c interferon in hairy cell leukemia].
    Werter MJ; Bogman MJ; Janssen JT; de Pauw BE; Haanen CA
    Ned Tijdschr Geneeskd; 1987 Nov; 131(46):2081-5. PubMed ID: 3683637
    [No Abstract]   [Full Text] [Related]  

  • 2. Quantitative analysis of bone marrow changes during the treatment of hairy cell leukemia with interferon alpha.
    Flandrin G; Sigaux F; Castaigne S; Degos L
    Cancer Treat Rev; 1985 Dec; 12 Suppl B():17-22. PubMed ID: 3833326
    [No Abstract]   [Full Text] [Related]  

  • 3. [Management of hairy cell leukemia with human leukocyte interferons].
    Ikkala E; Ala-Harja K; Almqvist A; Hallman H; Honkanen T; Pelliniemi TT; Timonen T
    Duodecim; 1987; 103(16):977-80. PubMed ID: 3454328
    [No Abstract]   [Full Text] [Related]  

  • 4. Hairy cell leukemia: an interferon deficient disease?
    Hofmann V; Fehr J; Sauter C; Ottino J
    Cancer Treat Rev; 1985 Dec; 12 Suppl B():33-7. PubMed ID: 3833328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Interferon-alpha therapy for hairy cell leukemia and lymphoproliferative disorders simulating hairy cell leukemia (hairy cell leukemia variant): a cooperative group study in Japan].
    Machii T; Kitani T; Kimura K; Maekawa I; Matsuzaki M; Mikuni C; Niikawa K; Igarashi T; Abe T; Miura Y
    Rinsho Ketsueki; 1988 Nov; 29(11):2029-36. PubMed ID: 3070073
    [No Abstract]   [Full Text] [Related]  

  • 6. Rapid improvement in a terminal case of hairy cell leukemia treated with a new human recombinant interferon, IFN-alpha-C.
    Aderka D; Levo Y; Rahmani R; Mory Y; Vaks B; Horowitz O; Doerner T; Shoham J; Wallach D; Revel M
    Isr J Med Sci; 1985 Dec; 21(12):977-81. PubMed ID: 4093298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of clinical efficacy and toxicity of conventional and optimum biological response modifying doses of interferon alpha-2C in the treatment of hairy cell leukemia: a retrospective analysis of 39 patients.
    Gastl G; Werter M; De Pauw B; Nerl C; Aulitzky W; von Lüttichau I; Tilg H; Thaler J; Lang A; Abbrederis K
    Leukemia; 1989 Jun; 3(6):453-60. PubMed ID: 2725061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha interferon for induction of remission in hairy-cell leukemia.
    Quesada JR; Reuben J; Manning JT; Hersh EM; Gutterman JU
    N Engl J Med; 1984 Jan; 310(1):15-8. PubMed ID: 6689734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results of treating 53 hairy cell leukemia patients with alpha-interferon.
    Flandrin G; Castaigne S; Sigaux F; Degos L
    Leukemia; 1987 Apr; 1(4):326-8. PubMed ID: 3669755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hairy cell leukemia achieved a complete remission after treatment with recombinant interferon-alpha: report of a case].
    Musashi M; Nakano M; Itasaka Y; Mitani R; Teng W; Kobayashi M; Saito N; Okabe M; Takemori N; Sakurada K
    Rinsho Ketsueki; 1986 Mar; 27(3):391-7. PubMed ID: 3735688
    [No Abstract]   [Full Text] [Related]  

  • 11. [Use of alpha-interferon in the treatment of hairy-cell leukemia].
    Pagnucco G; Castelli G; Lazzarino M; Bernasconi C
    Haematologica; 1990; 75 Suppl 4():56-67. PubMed ID: 2074056
    [No Abstract]   [Full Text] [Related]  

  • 12. Recombinant alpha-interferon (alpha-IFN) for progressive hairy-cell leukemia (HCL): a study in previously untreated nonsplenectomized patients.
    Schwarzinger I; Bettelheim P; Chott A; Herold C; Hinterberger W; Köller U; Kos M; Neumann E; Radaszkiewicz T; Lechner K
    Wien Klin Wochenschr; 1988 Jan; 100(2):47-51. PubMed ID: 3348041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Recombinant interferon alpha 2 in treatment of hairy cell leukemia].
    Hasselbalch H; Hippe E; Lisse IM; Nielsen B; Ellegaard J; Jensen MK
    Ugeskr Laeger; 1987 Aug; 149(35):2322-4. PubMed ID: 3451461
    [No Abstract]   [Full Text] [Related]  

  • 14. [Interferon-alpha in the treatment of hematologic neoplasms].
    Aulitzky W; Gastl G; Tilg H; Troppmair J; Leiter E; Geissler D; Flener R; Huber C
    Wien Med Wochenschr; 1986 Apr; 136(7-8):172-81. PubMed ID: 3524022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of hairy cell leukaemia with recombinant alpha-interferon.
    Bezwoda WR; Hesdorffer CS; Dansey RD; Lewis D
    S Afr Med J; 1987 Nov; 72(10):661-2. PubMed ID: 3686262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The UCLA experience with type I interferons in hairy cell leukemia.
    Glaspy JA; Jacobs AD; Golde DW
    Leukemia; 1987 Apr; 1(4):323-6. PubMed ID: 3312839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant alpha-2 interferon in the treatment of hairy cell leukemia.
    Thompson JA; Brady J; Kidd P; Fefer A
    Cancer Treat Rep; 1985; 69(7-8):791-3. PubMed ID: 4016788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Results of a phase II study on the treatment of hairy cell leukemias with various doses of alpha-2-recombinant interferon].
    Aulitzky W; Gastl G; Troppmair J; Tilg H; Abbrederis K; Nerl C; Flener R; Rokos H; Huber C
    Acta Med Austriaca; 1985; 12(5):115-21. PubMed ID: 3832745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. INTRON A (interferon alfa-2b): clinical overview.
    Spiegel RJ
    Cancer Treat Rev; 1985 Dec; 12 Suppl B():5-16. PubMed ID: 3914355
    [No Abstract]   [Full Text] [Related]  

  • 20. [Experience in treating patients with hairy-cell leukemia with a Soviet genetically engineered interferon].
    Lepkov SV; Kruglova GV; Volkova MA; Demina EA
    Ter Arkh; 1989; 61(7):133-6. PubMed ID: 2588131
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.